Pattern of respiratory syncytial virus epidemics in Finland: two-year cycles with alternating prevalence of groups A and B.
about
Genetic variability and molecular evolution of the human respiratory syncytial virus subgroup B attachment G proteinDefining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study.Impact of respiratory syncytial virus: the nurse's perspectiveReplacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidates.Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in BangkokComprehensive real-time epidemiological data from respiratory infections in Finland between 2010 and 2014 obtained from an automated and multianalyte mariPOCĀ® respiratory pathogen test.Examining strain diversity and phylogeography in relation to an unusual epidemic pattern of respiratory syncytial virus (RSV) in a long-term refugee camp in Kenya.RSV infection in infants and young children. What's new in diagnosis, treatment, and prevention?Respiratory syncytial virus genetic and antigenic diversity.Modeling the variations in pediatric respiratory syncytial virus seasonal epidemicsEmergence of ON1 genotype of human respiratory syncytial virus subgroup A in China between 2011 and 2015Multiplex assay for detection of strain-specific antibodies against the two variable regions of the G protein of respiratory syncytial virus.Molecular epidemiology of respiratory syncytial virus.Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review.Seasonal variations of 15 respiratory agents illustrated by the application of a multiplex polymerase chain reaction assay.Environmental drivers of the spatiotemporal dynamics of respiratory syncytial virus in the United States.Genetic variation in attachment glycoprotein genes of human respiratory syncytial virus subgroups a and B in children in recent five consecutive yearsDevelopment of safe and effective RSV vaccine by modified CD4 epitope in G protein core fragment (Gcf).Evaluating vaccination strategies for reducing infant respiratory syncytial virus infection in low-income settings.Progress in understanding and controlling respiratory syncytial virus: still crazy after all these yearsMolecular epidemiology of human respiratory syncytial virus in Uruguay: 1985-2001--a review.Genetic relatedness of infecting and reinfecting respiratory syncytial virus strains identified in a birth cohort from rural Kenya.The natural history of respiratory syncytial virus in a birth cohort: the influence of age and previous infection on reinfection and diseaseRespiratory syncytial virus: disease, development and treatment.Molecular analysis of respiratory syncytial virus reinfections in infants from coastal Kenya.Understanding the transmission dynamics of respiratory syncytial virus using multiple time series and nested models.Analysis of respiratory syncytial virus genetic variability with amplified cDNAs.Respiratory syncytial virus subgroup B dominance during one winter season between 1987 and 1992 in Vancouver, Canada.Does the viral subtype influence the biennial cycle of respiratory syncytial virus?Pattern recognition receptors and genetic risk for rsv infection: value for clinical decision-making?Emergency treatment of obstructive bronchitis: change from nebulizers to metered dose inhalers with spacers.Ten years' experience with year-round active surveillance of up to 19 respiratory pathogens in children.PCR for detection of respiratory viruses: seasonal variations of virus infections.A review of palivizumab and emerging therapies for respiratory syncytial virus.Salbutamol with metered dose inhalers with spacers - an established emergency treatment for preschool wheeze.RSV--a substantial slice of the airway disease burden and the way to a vaccine.Subgrouping of respiratory syncytial virus strains from Australia and Papua New Guinea by biological and antigenic characteristics.Clinical and Socioeconomic Burden of Respiratory Syncytial Virus Infection in Children.Respiratory syncytial virus infection and prevalence of subgroups A and B in Hawaii.
P2860
Q24531958-2E99892A-8481-4BA7-8716-9BAFC9FA6A09Q24806002-67430953-422B-4FF8-A802-8203103C27E1Q27023799-8B000C92-DF6F-493C-B8EC-A497627BC8F7Q27469749-671354B6-291F-4298-95EA-638CA1DFF0ABQ27477511-8ECCB8AA-03A9-4C40-B034-342828B0A176Q31035673-12A08147-B882-40E0-9436-DA878D277C72Q33612556-903B2832-5275-4391-91F6-D9B03E6561A9Q33802570-2136059F-284B-4044-9E61-0BD96F86CD53Q33812405-2E939FEA-9449-488C-82CC-D81CB6005958Q33879075-FA148973-55D1-47CA-8BAA-A3139962C55BQ33905939-B06B3543-5196-48C4-8261-4E207DED164EQ33943306-74B31D36-CC1A-43CB-9A57-64E0C9AB84E3Q34191801-C64489C8-B7D9-4546-BDE6-7280D6825670Q34307704-6D976959-B45F-46EB-B320-0CC168E66D03Q34606237-373693AD-F5F3-41BC-83BC-709A7BFEB636Q34631828-38E3DA5E-9BA1-41F5-9ABE-41FCA55CD379Q34876356-0268D866-EB57-4860-BFC9-FBBE9279DA63Q34999432-6E46CE62-573F-4115-A68F-AB8A1262C3F7Q35149594-8483838E-0DD4-4D52-B1F4-4A08BA1CE33CQ35213237-A58869F1-947F-459F-BC1F-523CF0CE0099Q35566601-87B5BF42-D6B9-40BA-B0B0-B25E6A41FB54Q36237202-4021BB1E-B6E4-4FBA-AE4A-E1A756771F49Q36330977-307B0500-63A2-47F0-9EE2-140C923ACD4EQ36347623-0C0D560C-6005-4256-80E4-CA35D1B23ABAQ36579192-3FE85F72-2EB8-4963-A476-5929E1160CEAQ36657856-E4F2A0AB-1C1E-4A9B-96E9-1A68C30A2D3EQ37046620-8E6E0061-AB96-41B0-8148-297B34B690DEQ37068022-88520F0E-03D8-41A0-A628-5703FA10FBC6Q37070531-F7AA405E-8C83-47C3-A2B2-8495F8B63BE8Q37343235-FD3036E2-218A-4F8C-A6C7-079AB0CD5DF0Q37801887-9D6A01EA-BDBB-41BE-9BD4-7084AAC39F80Q37852785-51C7AAA5-BB2F-4BEE-83F5-D68343DDEBA4Q37859603-A1E40656-C0B9-4BD8-9EE1-CCCEE1BDD358Q37912225-322ACA13-19A3-4EE7-8533-10F2B91ED30CQ37914882-5AAF9034-CAD7-4C1A-8CF8-2AD4AA728D39Q38035001-A6556DF1-8003-491F-BD94-E3489C0CEE8BQ38080195-AF1589C5-454F-471C-ACDA-2E6AA145F7EDQ39067091-999CED59-AB3A-43D9-93F1-7594364D053FQ39294045-7121D4DD-2C73-4B41-B612-10D7197E179DQ39389648-1C5A62AB-9536-48A8-AE3B-B67E51FE59D3
P2860
Pattern of respiratory syncytial virus epidemics in Finland: two-year cycles with alternating prevalence of groups A and B.
description
1991 nĆ® lÅ«n-bĆ»n
@nan
1991幓ć®č«ę
@ja
1991幓å¦ęÆęē«
@wuu
1991幓å¦ęÆęē«
@zh
1991幓å¦ęÆęē«
@zh-cn
1991幓å¦ęÆęē«
@zh-hans
1991幓å¦ęÆęē«
@zh-my
1991幓å¦ęÆęē«
@zh-sg
1991幓åøč”ęē«
@yue
1991幓åøč”ęē«
@zh-hant
name
Pattern of respiratory syncyti ...... prevalence of groups A and B.
@en
Pattern of respiratory syncyti ...... prevalence of groups A and B.
@nl
type
label
Pattern of respiratory syncyti ...... prevalence of groups A and B.
@en
Pattern of respiratory syncyti ...... prevalence of groups A and B.
@nl
prefLabel
Pattern of respiratory syncyti ...... prevalence of groups A and B.
@en
Pattern of respiratory syncyti ...... prevalence of groups A and B.
@nl
P356
P1476
Pattern of respiratory syncyti ...... prevalence of groups A and B.
@en
P304
P356
10.1093/INFDIS/163.3.464
P407
P577
1991-03-01T00:00:00Z